Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease

Journal of Rheumatology

Volumn 25, Issue 2, 1998, Pages 290-295

  Drouvalakis, Katerina A ^a,b   Buchanan, Russell R C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Rheumatology Unit

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Drug induced; Lupus anticoagulant; Systemic lupus erythematosus; Thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; CHLORPROMAZINE; LUPUS ANTICOAGULANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; QUINIDINE; QUININE;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0031935541     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Triplett DA, Brandt JT. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. Hematol Pathol 1988;2:121-43.
2. Feinstein DI. Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 1985;313:1348-50.
3. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591-609.
4. Alarcón-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482-8.
5. Harris EN, Gharavi AE, Hegde U, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985;59:234.
6. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
7. Bird MR, O'Neill AI, Buchanan RRC, Ibrahim NMA, Parkin D. Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage. Pathology 1995;27:136-9.
8. Canosa RT, de Olivera RM. Chlorpromazine induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol 1988;27:272-5.
9. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the standardisation of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
10. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678-82.
11. Exner T, Rickard KA, Kronenberg H. Studies on phospholipid in the action of a lupus coagulation inhibitor. Pathology 1975;7:319-28.
12. Staub HL, Harris EN, Khamashta MA, Savidge G, Chahade WH, Hughes GRV. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989;48:166-9.
13. Rauch J, Tannenbaum M, Tannenbaum H, et al. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986;261:9672-7.
14. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin Mλ coagulation inhibitor with phospholipid specificity. J Clin Invest 1980;66:397-405.
15. Kelsey PR, Stevenson KJ, Poller L: The diagnosis of lupus anticoagulants by the activated partial thromboplastin time - the central role of phosphatidylserine. Thromb Haemost 1984;52:172-5.
16. Stevenson KJ, Seddon JM. The role of lipids in the detection of lupus anticoagulant by the dilute Russell viper venom test: are platelets or reagents containing hexagonal HII phases necessary? Br J Haematol 1994;86:583-9.
17. Harris EN, Chan JKU, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive values of the anticardiolipin test. Arch Intern Med 1986;146:2153.
18. Triplett DA, Brandt JT, Musgrave KA, Orr C: The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988;259:550-4.
19. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986;68:869-74.
20. Liu HW, Wong KL, Lin CK, Wong WS, Tse PWT, Chan GTC. The reappraisal of dilute thromboplastin inhibition test in the diagnosis of lupus anticoagulant. Br J Haematol 1989;72:229-34.
21. Gibson J, Starling E, Date L, Rickard KA, Kronenberg H. Simplified screening procedure for detecting lupus inhibitor. J Clin Pathol 1988;41:226-31.
22. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemost 1991;65:320-2.
23. Drouvalakis KA, Buchanan RRC. Phospholipid specificity of lupus anticoagulants [abstract]. Lupus 1994;3:352.
24. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989;62:892-6.
25. Schick PK, Kurica KB, Chako GK: Location of phosphatidylethanolamine and phosphatidylserine in the human platelet membrane. J Clin Invest 1976;57:221-6.
26. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991;88:3069-73.
27. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210-6.
28. Pierangeli SS, Barker JH, Stikovac D, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994;71:670-4.
29. Asherson RA, Khamashta MA, Ordi-Ros J. et al. The primary antiphospholipid syndrome: Major clinical and serological features. Medicine 1989;68:366-74.
30. Cullis PR, de Kruijff B, Hope MJ, et al. Structural properties of lipids and their functional roles in biological membranes. In: Membrane fluidity in biology. In: Aloia RC, editor. Concepts of membrane structure. New York: Academic Press, 1983:39-81.
31. 2-glycoprotein-I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles. J Biol Chem 1995;270:25845-9.
32. 2-GPI dependent fashion [abstract]. Lupus 1996;5:558.
33. Sulawsky M, Villena F, Bagnara M, Sotomayor CP. Molecular interactions of quinidine with phospholipid bilayers. Z Naturforsch 1995;50:527-34.